Cartessa Aesthetics LLC v. Aesthetics Biomedical Incorporated

CourtDistrict Court, D. Arizona
DecidedMarch 1, 2021
Docket2:19-cv-05827
StatusUnknown

This text of Cartessa Aesthetics LLC v. Aesthetics Biomedical Incorporated (Cartessa Aesthetics LLC v. Aesthetics Biomedical Incorporated) is published on Counsel Stack Legal Research, covering District Court, D. Arizona primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cartessa Aesthetics LLC v. Aesthetics Biomedical Incorporated, (D. Ariz. 2021).

Opinion

1 WO 2 3 4 5 6 IN THE UNITED STATES DISTRICT COURT 7 FOR THE DISTRICT OF ARIZONA

9 Cartessa Aesthetics LLC, No. CV-19-05827-PHX-DWL

10 Plaintiff, ORDER

11 v.

12 Aesthetics Biomedical Incorporated,

13 Defendant. 14 Aesthetics Biomedical Incorporated,

15 Counter-Claimant,

16 v.

17 Cartessa Aesthetics LLC,

18 Counter-Defendant.

20 21 Pending before the Court is Plaintiff/Counter-Defendant Cartessa Aesthetics LLC’s 22 (“Cartessa”) motion to dismiss and/or strike certain counterclaims and an accounting 23 request asserted by Defendant/Counter-Claimant Aesthetic Biomedical, Inc. (“ABM”). 24 (Doc. 89.) For the following reasons, the motion is denied. 25 PROCEDURAL HISTORY 26 On December 16, 2019, Cartessa initiated this action. (Doc. 1.) 27 On January 14, 2020, Cartessa filed a first amended complaint (“FAC”). (Doc. 9.) 28 On February 11, 2020, ABM filed an answer to the FAC. (Doc. 20.) In the same 1 document, ABM asserted the following seven counterclaims against Cartessa: (1) breach 2 of contract; (2) breach of the implied covenant of good faith and fair dealing; (3) tortious 3 interference with contractual agreements; (4) negligent/fraudulent misrepresentation; (5) 4 conversion of customer payments and Vivace units; (6) replevin; and (7) defamation. (Id. 5 at 20-25.)1 6 On March 3, 2020, Cartessa filed an answer to ABM’s counterclaims. (Doc. 27.) 7 On March 12, 2020, the parties filed the Rule 26(f) report. (Doc. 34.) Among other 8 things, the parties agreed that July 31, 2020 would be an acceptable deadline for the 9 completion of fact discovery. (Id. at 2, 8.) 10 On June 18, 2020, the parties jointly requested a referral to a magistrate judge for a 11 settlement conference. (Doc. 57.) This request was granted (Doc. 58) but the parties were 12 unable to reach a settlement during the resulting settlement conference (Doc. 64). 13 On August 12, 2020, the parties filed a joint status report that, among other things, 14 included new proposed case management deadlines. (Docs. 67, 67-1.) 15 On August 13, 2020, the Court issued an order accepting the parties’ proposed dates. 16 (Doc. 69.) Although the Court did not alter the deadline for amending the pleadings 17 (because it had already expired and the parties did not request a retroactive extension), the 18 Court extended the deadline for final supplementation of MIDP responses and the 19 completion of fact discovery (except for depositions) to September 30, 2020 and the 20 deadline for completing fact-witness depositions to December 11, 2020. (Id.) 21 On September 24, 2020—that is, six days before the deadline for completing fact 22 discovery—the parties filed a joint stipulation for leave to allow amendments to the 23 pleadings. (Doc. 73.) Upon receipt of this stipulation, the Court clarified that leave of 24 court was unnecessary under Local Rule 15.1(b) in light of the parties’ written consent to 25 the dueling amendments. (Doc. 74.) 26 On September 28, 2020, pursuant to the parties’ stipulation, Cartessa filed its second

27 1 This pleading also includes what purports to be an additional counterclaim against Cartessa for “injunctive relief” (Doc. 20 at 27-28), but this is best categorized as a request 28 for a particular form of relief (as opposed to an independent theory on which liability might be premised). 1 amended complaint (“SAC”). (Doc. 80.) 2 On October 15, 2020, ABM filed its answer to the SAC. (Doc. 88.) In the same 3 document, and pursuant to the parties’ stipulation, ABM also asserted three new 4 counterclaims (with the new count numbers denoted in parentheses): (8) unfair competition 5 under the Lanham Act, 18 U.S.C. § 1125; (9) false advertising under the Lanham Act, 18 6 U.S.C. § 1125; (10) tortious interference with ABM’s contractual agreement with SheNB. 7 (Doc. 85-1 at 54-58 [denoting changes in redline]; Doc. 88 at 33-38 [final version].) ABM 8 also requested one additional form of relief that it hadn’t requested in its initial set of 9 counterclaims: a request for an accounting. (Doc. 85-1 at 36; Doc. 88 at 18.) 10 On October 26, 2020, Cartessa filed the pending motion to dismiss and/or strike 11 certain counterclaims and the accounting request. (Doc. 89.) 12 On October 30, 2020, ABM moved to amend the scheduling order. (Doc. 90.) 13 On November 9, 2020, ABM filed a response to Cartessa’s motion to dismiss and/or 14 strike. (Doc. 97.) 15 On November 13, 2020, the Court issued an order granting ABM’s motion to amend 16 the scheduling order to the extent it sought a 90-day extension of “all non-expired 17 deadlines.” (Doc. 99.) In other words, this order extended the deadline for completing 18 fact-witness depositions (from December 2020 to March 2021) but did not extend the 19 already-expired deadline for all other forms of fact discovery. (Id.) 20 On November 16, 2020, Cartessa filed a reply in support of its motion to dismiss 21 and/or strike. (Doc. 100.)2 22 DISCUSSION 23 Cartessa moves, pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure, 24 to dismiss ABM’s fourth, eighth, ninth, and tenth counterclaims in full and to dismiss 25 ABM’s first, fifth, and sixth counterclaims in part. (Doc. 89.) Cartessa also moves to 26 dismiss and/or “strike” ABM’s request for an accounting. (Id.) In response, ABM defends 27 the sufficiency of all of its challenged counterclaims and its accounting request and

28 2 Cartessa’s request for oral argument is denied because the issues are fully briefed and oral argument would not assist the Court’s decisional process. See LRCiv 7.2(f). 1 additionally argues that Cartessa’s motion should be denied in full or in part for the 2 procedural reasons of (1) non-compliance with Local Rule 12.1(c) and (2) untimeliness. 3 (Doc. 97.) 4 I. Local Rule 12.1(c) 5 Local Rule of Civil Procedure 12.1(c) provides that “[n]o motion to dismiss for 6 failure to state a claim or counterclaim, pursuant to Federal Rule of Civil Procedure 7 12(b)(6), or motion for judgment on the pleadings on a claim or counterclaim, pursuant to 8 Federal Rule of Civil Procedure 12(c), will be considered or decided unless the moving 9 party includes a certification that, before filing the motion, the movant notified the 10 opposing party of the issues asserted in the motion and the parties were unable to agree that 11 the pleading was curable in any part by a permissible amendment offered by the pleading 12 party.” Id. The rule further provides that “[t]he movant may comply with this rule through 13 personal, telephonic, or written notice of the issues that it intends to assert in a motion.” 14 Id. “A motion that does not contain the required certification may be stricken summarily.” 15 Id. 16 Here, Cartessa attempted to comply with Local Rule 12.1(c) by including a footnote 17 in its motion stating that it “notified ABM of the issues asserted herein at a telephone 18 conference on October 23, 2020 and by letter dated August 14, 2020” and that “[t]he parties 19 were unable to agree that the pleading was curable by amendment.” (Doc. 89 at 1 n.2.) 20 Cartessa also included, as an attachment, the August 14, 2020 letter. (Doc. 89-5.) 21 ABM challenges the sufficiency of Cartessa’s meet-and-confer efforts. (Doc.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Whittlestone, Inc. v. Handi-Craft Co.
618 F.3d 970 (Ninth Circuit, 2010)
Grajales v. Puerto Rico Ports Authority
682 F.3d 40 (First Circuit, 2012)
Jose Chavez v. James Ziglar
683 F.3d 1102 (Ninth Circuit, 2012)
A. R. A. Manufacturing Co. v. Pierce
341 P.2d 928 (Arizona Supreme Court, 1959)
Platte Anchor Bolt, Inc. v. IHI, INC.
352 F. Supp. 2d 1048 (N.D. California, 2004)
ChartOne, Inc. v. Bernini
83 P.3d 1103 (Court of Appeals of Arizona, 2004)
United States v. Habibi
783 F.3d 1 (First Circuit, 2015)
Meghan Mollett v. Netflix, Inc.
795 F.3d 1062 (Ninth Circuit, 2015)
Robert Pepper v. Apple, Inc.
846 F.3d 313 (Ninth Circuit, 2017)
Williams Hicks v. Pga Tour, Inc.
897 F.3d 1109 (Ninth Circuit, 2018)
Lu v. Menino
98 F. Supp. 3d 85 (D. Massachusetts, 2015)
Nevada Power Co. v. Monsanto Co.
151 F.R.D. 118 (D. Nevada, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
Cartessa Aesthetics LLC v. Aesthetics Biomedical Incorporated, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cartessa-aesthetics-llc-v-aesthetics-biomedical-incorporated-azd-2021.